- Home
- ROIV vs LYB Comparison
ROIV vs LYB Comparison
Compare ROIV & LYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | LYB |
|---|---|---|
| Founded | 2014 | 1955 |
| Country | United Kingdom | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7B | 17.3B |
| IPO Year | 2021 | 2010 |
Fundamental Metrics
Financial Performance| Metric | ROIV | LYB |
|---|---|---|
| Price | $28.05 | $72.24 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 15 |
| Target Price | $27.56 | ★ $60.93 |
| AVG Volume (30 Days) | 4.8M | ★ 7.8M |
| Earning Date | 05-11-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 3.71% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $29,053,000.00 | ★ $30,153,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $385.85 | $0.70 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $41.58 |
| 52 Week High | $30.33 | $75.62 |
Technical Indicators
Market Signals| Indicator | ROIV | LYB |
|---|---|---|
| Relative Strength Index (RSI) | 53.51 | 74.77 |
| Support Level | $26.94 | $43.01 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 1.01 | 3.05 |
| MACD | -0.21 | 1.15 |
| Stochastic Oscillator | 32.70 | 88.35 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About LYB LyondellBasell Industries NV (Netherlands)
LyondellBasell is a petrochemical producer with operations in the United States, Europe, and Asia. The company is the world's largest producer of polypropylene and also a major producer of polyethylene and propylene oxide. Its chemicals are used in various consumer and industrial end products. Well over half of LyondellBasell's production comes from its North American operations.